Market Exclusivity Case Study: XIFAXAN (rifaximin)
Posted on07 May 2020
Comments0
Bausch Health Companies Inc. along with its wholly owned subsidiary, Salix Pharmaceuticals, which is one of the largest specialty pharmaceutical companies in... Read More
Glenmark Foundation rolls out tele-health solution to expand access to quality patient care
Glenmark Foundation, the CSR arm of Glenmark Pharmaceuticals along with its NGO partners, has launched a tele-health solution in partnership with its... Read More
Florio GmbH introducing new digital platform aiming to improve the lives of people with haemophilia
Swedish Orphan Biovitrum AB (publ) (Sobi) has announced the launch by its affiliate, Florio GmbH, of Florio, a digital medical device designed... Read More
Who determines when a prescription medicine should be switched to OTC status?
Posted on07 Apr 2020
Comments0
Technically, anyone could submit a Citizen’s Petition to FDA to switch a product from Rx to OTC status. However, the holder of... Read More
Evox partnership with Takeda Pharmaceutical for rare disease
Evox Therapeutics Ltd, a leading exosome therapeutics company, announced the signing of a rare disease-focused partnership with Takeda Pharmaceutical Company Limited. The... Read More
A case based understanding in co-development deal
In a Co-Development Agreement the intellectual property is typically licensed by the licensor to the alliance partner, and as well, the two... Read More
ProBiotix Health has signed a distribution licensing agreement with Velinoff Pharma in Bulgaria
UK-based life sciences business OptiBiotix Health said that its unit ProBiotix Health has signed a licensing agreement with Bulgarian pharmaceutical marketing company... Read More
Regeneron, Sanofi initiates clinical trial in Kevzara to treat COVID-19
Regeneron Pharmaceuticals and Sanofi have started a clinical programme evaluating Kevzara (sarilumab) in patients hospitalized with severe coronavirus (COVID-19) infection. Kevzara is... Read More
Cipla launches GLYCOHALE respule
Cipla has annouced the introduction of Glycohale Respules. This helps Cipla to strengthen the Respiratory portfolio. Glycopyrrolate inhalation is indicated for the... Read More
Sun Pharma launched “Take on acne” campaign
Sun Dermatology, a division of Sun Pharmaceutical Industries, Inc., USA, which is a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (together... Read More